Pro-brain-derived neurotrophic factor is decreased in parietal cortex in Alzheimer's disease

Molecular Brain Research

Volumn 111, Issue 1-2, 2003, Pages 148-154

  Michalski, Bernadeta ^a   Fahnestock, Margaret ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

Brain derived neurotrophic factor (BDNF); Human; Neurotrophin; Postmortem; Precursor; Proprotein; Western blotting

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN CORTEX; BRAIN DEVELOPMENT; BRAIN LEVEL; CADAVER; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; MALE; PARIETAL LOBE; PRIORITY JOURNAL;

EID: 0037451044     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(03)00003-2     Document Type: Article

References (30)

1. Alderson R.F., Alterman A.L., Barde Y.A., Lindsay R.M. Brain-derived neurotrophic factor increases survival and differentiated functions of rat septal cholinergic neurons in culture. Neuron. 5:1990;297-306.
2. Bresnahan P.A., Leduc R., Thomas L., Thorner J., Gibson H.L., Brake A.J., Barr P.J., Thomas G. Human fur gene encodes a yeast KEX2-like endoprotease that cleaves pro-β-NGF in vivo. J. Cell Biol. 111:1990;2851-2859.
3. Connor B., Young D., Yan Q., Faull R.L., Synek B., Dragunow M. Brain-derived neurotrophic factor is reduced in Alzheimer's disease. Mol. Brain Res. 49:1997;71-81.
4. Coyle J.T., Price D.L., DeLong M.R. Alzheimer's disease: a disorder of cortical cholinergic innervation. Science. 219:1983;1184-1190.
5. Durany N., Michel T., Kurt J., Cruz-Sanchez F.F., Cervas-Navarro J., Riederer P. Brain-derived neurotrophic factor and neurotrophin-3 levels in Alzheimer's disease brains. Int. J. Dev. Neurosci. 18:2000;807-813.
6. Fahnestock M., Michalski B., Xu B., Coughlin M.D. The precursor pro-nerve growth factor is the predominant form of nerve growth factor in brain and is increased in Alzheimer's disease. Mol. Cell. Neurosci. 18:2001;210-220.
7. Fahnestock M., Scott S.A., Jetté N., Weingartner J.A., Crutcher K.A. Nerve growth factor mRNA and protein levels measured in the same tissue from normal and Alzheimer's disease parietal cortex. Mol. Brain Res. 42:1996;175-178.
8. Ferrer I., Marin C., Rey M.J., Ribalta T., Goutan E., Blanco R., Tolosa E., Marti E. BDNF and full-length and truncated TrkB expression in Alzheimer disease. Implications in therapeutic strategies. J. Neuropathol. Exp. Neurol. 58:1999;729-739.
9. Garzon D., Yu G., Fahnestock M. A new brain-derived neurotrophic factor transcript and decrease in brain-derived neurotrophic factor transcripts 1, 2 and 3 in Alzheimer's disease parietal cortex. J. Neurochem. 82:2002;1058-1064.
10. Goedert M., Fine A., Hunt S.P., Ullrich A. Nerve growth factor mRNA in peripheral and central rat tissues and in the human central nervous system: lesion effects in the rat brain and levels in Alzheimer's disease. Brain Res. 387:1986;85-92.
11. Hefti F., Weiner W.J. Nerve growth factor and Alzheimer's disease. Ann. Neurol. 20:1986;275-281.
12. Hock C., Heese K., Hulette C., Rosenberg C., Otten U. Region-specific neurotrophin imbalances in Alzheimer disease: decreased levels of brain-derived neurotrophic factor and increased levels of nerve growth factor in hippocampus and cortical areas. Arch. Neurol. 57:2000;846-851.
13. Holsinger R.M.D., Schnarr J., Henry P., Castelo V.T., Fahnestock M. Quantitation of BDNF mRNA in human parietal cortex by competitive reverse transcription-polymerase chain reaction: decreased levels in Alzheimer's disease. Mol. Brain Res. 76:2000;347-354.
14. Jetté N., Cole M., Fahnestock M. NGF mRNA is not decreased in frontal cortex from Alzheimer's disease patients. Mol. Brain Res. 25:1994;242-250.
15. Katoh-Semba R., Takeuchi I.K., Semba R., Kato K. Distribution of brain-derived neurotrophic factor in rats and its changes with development in the brain. J. Neurochem. 69:1997;34-42.
16. Khachaturian Z.S. Diagnosis of Alzheimer's disease. Arch. Neurol. 42:1985;1097-1105.
17. Lee R., Kermani P., Teng K.K., Hempstead B.L. Regulation of cell survival by secreted proneurotrophins. Science. 294:2001;1945-1948.
18. Mann D.M. Is the pattern of nerve cell loss in aging and Alzheimer's disease a real, or only an apparent, selectivity? Neurobiol. Aging. 12:1991;340-343.
19. Marcinkiewicz M., Savaria D., Marcinkiewicz J. The pro-protein convertase PC1 is induced in the transected sciatic nerve and is present in cultured Schwann cells: comparison with PC5, furin and PC7, implication in pro-BDNF processing. Mol. Brain Res. 59:1998;229-246.
20. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 34:1984;939-944.
21. Mowla S.J., Farhadi H.F., Pareek S., Atwal J.K., Morris S.J., Seidah N.G., Murphy R.A. Biosynthesis and posttranslational processing of the precursor to brain derived neurotrophic factor. J. Biol. Chem. 276:2001;12660-12666.
22. Murer M.G., Yan Q., Raisman-Vozari R. Brain-derived neurotrophic factor in the control human brain, and in Alzheimer's disease and Parkinson's disease. Prog. Neurobiol. 63:2001;71-124.
23. Murray K.D., Gall C.M., Jones E.G., Isackson P.J. Differential regulation of brain-derived neurotrophic factor and type II calcium/calmodulin-dependent protein kinase messenger RNA expression in Alzheimer's disease. Neuroscience. 60:1994;37-48.
24. Narisawa-Saito M., Wakabayashi K., Tsuji S., Takahashi H., Nawa H. Regional specificity of alterations in NGF, BDNF and NT-3 levels in Alzheimer's disease. Neuroreport. 7:1996;2925-2928.
25. Phillips H.S., Hains J.M., Armanini M., Laramee G.R., Johnson S.A., Winslow J.W. BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer's Disease. Neuron. 7:1991;695-702.
26. Rylett R.J., Williams L.R. Role of neurotrophins in cholinergic-neurone function in the adult and aged CNS. Trends Neurosci. 17:1994;486-490.
27. Seidah N.G., Benjannet S., Pareek S., Chrétien M., Murphy R.A. Cellular processing of the neurotrophin precursors of NT3 and BDNF by the mammalian proprotein convertases. FEBS Lett. 379:1996;247-250.
28. Seidah N.G., Benjannet S., Pareek S., Savaria D., Hamelin J., Goulet B., Laliberté J., Lazure C., Chrétien M., Murphy R.A. Cellular processing of the nerve growth factor precursor by the mammalian pro-protein convertases. Biochem. J. 314:1996;951-960.
29. Whitehouse P., Price D., Struble R., Clarke A., Coyle J., Delong M. Alzheimer's disease and senile dementia: loss of neurones in the basal forebrain. Science. 215:1982;1237-1239.
30. G. Yu, B. Michalski, S. Mathew, M.D. Coughlin, M. Fahnestock, The nerve growth factor precursor exhibits biological activity similar to that of mature NGF, Society for Neuroscience (2002) Program No. 332.2, Abstract Viewer/Itinerary Planner, Online, http://sfn.scholarone.com/itin2002/.